Ken Griffin’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Ken Griffin’s Portfolio MYOK Stock Details MYOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-24,900	Closed	-$3.4M	–	11858
2020 Q3	$3.4M	Sell	24,900 -34,600	-58%	-$3.68M	﹤0.01%	3777
2020 Q2	$5.75M	Sell	59,500 -74,300	-56%	-$6.2M	﹤0.01%	2895
2020 Q1	$6.27M	Buy	133,800 +39,700	+42%	+$2.54M	﹤0.01%	2430
2019 Q4	$6.86M	Buy	+94,100	New	+$5.71M	﹤0.01%	2668

Ken Griffin's MYOK Position: Q3 2020 in Review

Ken Griffin sold out of MyoKardia, Inc. Common Stock (MYOK) in Q3 2020, closing a stake of 146,932 shares — an estimated $15.6M sold.

Ken Griffin first reported a position in MYOK in Q4 2016 and held it in 13 quarters. The position peaked at $14.2M in Q2 2020. 237 funds tracked by Wall St. Rank hold MYOK as of Q3 2020.

Ken Griffin reported no remaining MyoKardia, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
Ken Griffin sold 146,932 MyoKardia, Inc. Common Stock shares in Q3 2020, an estimated $15.6M.
Ken Griffin first reported a position in MyoKardia, Inc. Common Stock in Q4 2016 and held it in 13 quarters.
Ken Griffin's MyoKardia, Inc. Common Stock position peaked at $14.2M in Q2 2020.
237 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q3 2020.

Based on Citadel Advisors's 13F filing for Q3 2020, filed 16 Nov 2020.